Author:
Maruszak Wioleta,Cybulski Marcin
Funder
European Commission
European Regional Development Fund
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference30 articles.
1. TRITRON and BEYOND: New insights into the profile of prasugrel;Jakubowski;Cardiovasc. Ther.,2012
2. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology;Clemmensen;Cardiovasc. Drug. Ther.,2013
3. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)–Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy
4. H. Koike, F., Asai, A., Sugidachi, T., Kimura, T., Inoue, S, Nishino, Y. Tsuzaki, Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation. US 5288726, 1994.
5. K. Ataka, H., Miyata, M., Kono, N. Yokota, Y. Yamamoto 2-silyloxytetrahydrothienopyridine, salt thereof and process for producing the same. EP 0785205 B1, 2002.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献